Skip to content
ClosedNo longer accepting applications

FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)

Food and Drug Administration

About this archived opportunity

The purpose of the FDA (R13) Scientific Conference Grant Program is to facilitate the provision of federal financial assistance in support of high-quality conferences and scientific meetings designed to research and investigate a topic clearly aligned with the FDA mission. The FDA recognizes the value of supporting high quality conferences and scientific meetings relevant to its mission and to the public health. A conference or scientific meeting is defined as a symposium, seminar, workshop, or any formal meeting, whether conducted face-to-face or virtually to exchange information and explore a defined subject, issue, or area of concern impacting the public's health within the scope of the FDA's mission. Permission to submit a conference grant application does not assure funding or funding at the level requested. FDA will not issue a conference grant award unless it can be issued before the conference start date.

Historical details

Status
Closed
Deadline
January 30, 2026
First captured
January 13, 2026
Publisher reference
344880

Eligibility: Foreign Institutions are not eligible to apply

This opportunity has closed

FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)

by Food and Drug Administration

Get notified when similar opportunities open

We'll save this search and email you when new support, conferences, scientific opportunities are posted. Free.

Refine this search